Phase 2 Trial of Single-agent Everolimus in Chemotherapy-naive Patients with Castration-resistant Prostate Cancer (SAKK 08/08)
Arnoud J. Templeton(Kantonsspital St. Gallen), Valérie Dutoit(University Hospital of Geneva), Richard Cathomas(Kantonsspital Graubünden), Christian Rothermundt(Kantonsspital St. Gallen), Daniela Bärtschi(Swiss Group For Clinical Cancer Research), Cornelia Dröge(University Hospital of Basel), Oliver Gautschi(University Hospital of Bern), Markus Borner(Spitalzentrum Centre hospitalier Biel- Bienne), Eva Fechter(Kantonsspital Winterthur), Frank Stenner(University Hospital of Zurich), Ralph Winterhalder(Luzerner Kantonsspital), Beat P. Müller‐Stich(Kantonsspital Aarau), Ralph Schiess(ETH Zurich), Peter J. Wild(University Hospital of Zurich), Jan H. Rüschoff(University Hospital of Zurich), George N. Thalmann(University Hospital of Bern), Pierre‐Yves Dietrich(University Hospital of Geneva), Ruedi Aebersold(ETH Zurich), Dirk Klingbiel(Swiss Group For Clinical Cancer Research), Silke Gillessen(Kantonsspital St. Gallen)
Cited by 129
Abstract
Related Papers
No related papers found
Powered by citation graph analysis